Cutaneous reactions to imatinib mesylate treated by topical steroid [2]

American Journal of Hematology

Volumn 78, Issue 3, 2005, Pages 246-

  Ujiie, Hideyuki ^a   Shimizu, Tadamichi ^a   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCLOMETASONE DIPROPIONATE; DIFLUPREDNATE; IMATINIB; STEROID;

ADULT; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DRUG WITHDRAWAL; ERYTHEMA; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LETTER; LIVER METASTASIS; MALE; PRIORITY JOURNAL; RASH; SHORT COURSE THERAPY; SKIN MANIFESTATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANTINEOPLASTIC AGENTS; BETAMETHASONE; DRUG ERUPTIONS; FLUPREDNISOLONE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; OINTMENTS; PIPERAZINES; PYRIMIDINES; STEROIDS;

EID: 14644427729     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20267     Document Type: Letter

References (5)

1. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-480.
2. Rule SA, O'Brien SG, Crossman LC. Managing cutaneous reactions to imatinib therapy. Blood 2002;100:3434-3435.
3. Brouard MV, Saurat JH. Cutaneous reactions to STI571. N Engl J Med 2001;345:618-619.
4. Hsiao LT, Chung HM, Lin JT, et al. Stevens-Johnson syndrome after treatment with STI571: a case report. Br J Haematol 2002;117:620-622.
5. Sanchez-Gonzalez B, Pascual-Ramirez JC, Fernandez-Abellan P, Belinchon-Romero J, Rivas C, Vegara-Aguilera G. Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia. Blood 2003;101:2446.